[CHRS] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -16.61%
YoY- 162.67%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 113,551 135,674 116,180 123,856 111,684 83,433 37,098 110.38%
PBT 28,116 60,325 36,505 41,271 47,890 23,618 -20,004 -
Tax 183 1,294 933 2,044 847 51 5,027 -88.94%
NP 27,933 59,031 35,572 39,227 47,043 23,567 -20,004 -
Tax Rate -0.65% -2.15% -2.56% -4.95% -1.77% -0.22% - -
Total Cost 85,618 76,643 80,608 84,629 64,641 59,866 57,102 30.90%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 24.60 43.51 30.62 31.67 42.12 28.25 -53.92 -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS 0.39 0.83 0.50 0.56 0.67 0.34 -0.29 -
EPS Diluted 0.33 0.70 0.48 0.53 0.63 0.32 -0.29 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.